Company: PBH
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001295947-25-000039
Chunk: 11

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 2
Chunk 11
---
CD") model rules that propose a global minimum tax rate of 15%.  Certain countries have enacted, or are in the process of 

21

enacting, legislation to address the global minimum tax.  This legislation has not and is not expected to have a material impact on our Consolidated Financial Statements.  As legislation becomes effective in more countries in which we do business, our taxes could increase and negatively impact our provision for income taxes.  We continue to monitor pending legislation and implementation by countries and to evaluate the potential impact on our business in future periods.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act, including 100% bonus depreciation, domestic research cost expensing, and the business interest expense limitation. We are continuing to assess its impact and do not expect the OBBBA to have a material impact on our estimated annual effective tax rate. 

22

Results of Operations 

Three Months Ended September 30, 2025 compared to the Three Months Ended September 30, 2024

Total Segment Revenues

The following table represents total revenue by segment, including product groups, for the three months ended September 30, 2025 and 2024.

Three Months Ended September 30, Increase (Decrease)(In thousands)2025%2024%Amount%North American OTC HealthcareAnalgesics$27,232 9.9 $27,147 9.6 $85 0.3 Cough & Cold20,472 7.5 23,054 8.1 (2,582)(11.2)Women's Health50,588 18.5 54,309 19.1 (3,721)(6.9)Gastrointestinal46,413 16.9 41,911 14.8 4,502 10.7 Eye & Ear Care29,387 10.7 36,140 12.7 (6,753)(18.7)Dermatologicals32,792 12.0 33,640 11.9 (848)(2.5)Oral Care21,039 7.7 20,698 7.3 341 1.6 Other OTC2,833 1.0 2,912 1.